Investigating the evolution of complex trimethoprim and ciprofloxacin resistance phenotypes in E. coli and their impact on bacteriophage virulence

Read full text Summarise with VIRAT
Authors: Angus Quinn
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The spread of antibiotic resistance among bacterial pathogens remains one of the largest challenges facing humanity. Understanding the processes driving resistance evolution and their impact on the application of novel antimicrobials, is essential for resolving the global crisis. Despite this, we have very limited understanding of how antibiotic resistance mechanisms interact to form complex phenotypes, especially over different genetic backgrounds, and the impact of antibiotic resistance on alternative treatments such as bacteriophages. In this study, I experimentally evolved single-drug and multi-drug resistance across 63 independent Escherichia coli populations, against three antibiotics: trimethoprim, ciprofloxacin and ampicillin. This was performed across three genomically distinct E. coli strains: 55-989, CFT-073 and BREL-606. In total 103 mutants were isolated and phenotypically characterised before full genome sequencing. The impact of trimethoprim resistance evolution on subsequent infection by bacteriophages was also assessed via virulence index assays. I found antibiotic resistance evolved through a diverse array of evolutionary mechanisms targeting stress response genes, efflux pump regulators, RNA polymerase modifications, nucleotide biosynthesis and RNA degradation pathways. This highlighted several mutations outside of the well-known resistance markers, alongside the role of rare low-frequency mutations, particularly in trimethoprim resistance. Clear strain specific differences in evolutionary trajectories emerged, dramatically influencing the adaptive landscape. Furthermore, I found that trimethoprim resistance evolution significantly increased tolerance to bacteriophages, reducing phages’ capacity to infect and kill resistant lineages. This primarily caused by mutations in large gene network regulators: marR, phoQ and mgrB. This research provides a comprehensive overview of how complex trimethoprim and ciprofloxacin resistance phenotypes evolve in E. coli and how resistance to trimethoprim impacts bacteriophage treatment. These results could help improve resistance surveillance and inform treatment decisions for bacteriophage therapy, particularly for multi-drug resistant infections.

Fields of Study & Subjects

Evolution and Genetic Dynamics Antibiotic Resistance in Bacteria Bacterial Genetics and Biotechnology

Publication details

Journal / source
Warwick Research Archive Portal (University of Warwick)
Publication date
17 September 2026
Language
EN
Document type
Thesis